OMIC Logo

Singular Genomics Systems, Inc. (OMIC) 

NASDAQ
Market Cap
$54.43M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
84 of 775
Rank in Industry
4 of 48

Largest Insider Buys in Sector

OMIC Stock Price History Chart

OMIC Stock Performance

About Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile …

Insider Activity of Singular Genomics Systems, Inc.

Over the last 12 months, insiders at Singular Genomics Systems, Inc. have bought $1.81M and sold $17,835 worth of Singular Genomics Systems, Inc. stock.

On average, over the past 5 years, insiders at Singular Genomics Systems, Inc. have bought $8.82M and sold $189,911 worth of stock each year.

Highest buying activity among insiders over the last 12 months: TANG KEVIN (10 percent owner) — $1.81M.

The last purchase of 32,000 shares for transaction amount of $550,720 was made by TANG KEVIN (10 percent owner) on 2024‑09‑18.

List of Insider Buy and Sell Transactions, Singular Genomics Systems, Inc.

2024-11-12SaleChief Executive Officer
695
0.0273%
$22.55$15,669-3.29%
2024-09-18Purchase10 percent owner
32,000
1.3143%
$17.21$550,720-8.67%
2024-09-17Purchase10 percent owner
40,000
1.5204%
$15.33$613,200-4.83%
2024-09-16Purchase10 percent owner
50,416
2.0091%
$12.74$642,300+20.06%
2024-09-15SaleChief Executive Officer
175
0.007%
$12.38$2,167+13.08%
2023-11-17PurchaseChief Executive Officer
75,000
0.1012%
$0.42$31,755-3.96%
2023-11-16PurchaseChief Scientific Officer
200,000
0.272%
$0.43$85,640-1.18%
2023-11-16PurchaseChief Executive Officer
43,468
0.0567%
$0.41$17,857-1.18%
2023-08-15Saledirector
200,000
0.2773%
$0.53$106,960-24.02%
2023-08-14Saledirector
77,991
0.1139%
$0.57$44,424-24.82%
2023-08-11Saledirector
353,657
0.5041%
$0.60$210,603-29.80%
2023-05-17PurchaseChief Scientific Officer
170,000
0.2422%
$0.82$138,924-41.05%
2022-12-12PurchaseChief Scientific Officer
50,000
0.0743%
$2.00$100,000-53.90%
2022-05-18Purchase
26,834
0.0412%
$3.30$88,552-19.74%
2021-06-01Purchase10 percent owner
1.5M
3.3473%
$22.00$33M-62.91%

Insider Historical Profitability

<0.0001%
TANG KEVIN10 percent owner
372000
14.8102%
$21.6730
Spaventa AndrewChief Executive Officer
1537
0.0612%
$21.6722
Flynn James E10 percent owner
7484871
297.9907%
$21.6710<0.0001%
Glezer Eli N.Chief Scientific Officer
4570000
181.9427%
$21.6730<0.0001%
Pellini Michael J
99289
3.9529%
$21.6710<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Deerfield Management$2.56B201.844.98M0%+$06.25
Arch Venture Management Llc$1.95B153.823.8M0%+$096.36
Qvidtvm Management Llc$1.29B101.52.51M+8.06%+$96.18M91.29
UBS$1.14B89.462.21M+<0.01%+$16,962.000.34
Perceptive Advisors$1.09B86.122.13M0%+$00.7
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.